Dudediligence.

Harmony Biosciences Holdings, Inc

HRMYNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$186.0MSep ’24$201.3MDec ’24$184.7MMar ’25$200.5MJun ’25$239.5MSep ’25$243.8MDec ’25$215.4MMar ’26$261.3MJun ’26
Net income, by quarter
$46.1MSep ’24$49.5MDec ’24$45.6MMar ’25$39.8MJun ’25$50.9MSep ’25$22.5MDec ’25$32.5MMar ’26$75.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$305.4M$437.9M$582.0M$714.7M$868.5M
Gross profit$249.9M$354.4M$460.8M$557.9M$670.1M
Operating income$87.5M$120.2M$192.0M$190.8M$208.5M
Net income$34.6M$181.5M$128.9M$145.5M$158.7M
Operating cash flow$98.6M$144.5M$219.4M$219.8M$348.2M
Free cash flow$98.3M$144.3M$219.1M$218.7M$347.9M
Cash$234.3M$243.8M$311.7M$453.0M$752.5M
Debt$192.0M$191.6M$193.6M$179.3M$163.7M
Shares outstanding58.8M59.6M56.8M57.1M57.7M